Back to Search Start Over

Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation

Authors :
Yuefeng Huang
Yasmine Belkaid
David Artis
Fred P. Davis
Françoise Meylan
Oliver J. Harrison
Hiroyuki Nagashima
Yuka Kanno
Chen Yao
Kathleen M. Caron
John J. O'Shea
Joseph F. Urban
Han-Yu Shih
Yohei Mikami
Tanel Mahlakõiv
Source :
Immunity
Publication Year :
2019

Abstract

Innate lymphocytes maintain tissue homeostasis at mucosal barriers, with group 2 innate lymphoid cells (ILC2s) producing type 2 cytokines and controlling helminth infection. While the molecular understanding of ILC2 responses has advanced, the complexity of microenvironmental factors impacting ILC2s is becoming increasingly apparent. Herein, we used single-cell analysis to explore the diversity of gene expression among lung lymphocytes during helminth infection. Following infection, we identified a subset of ILC2s that preferentially expressed Il5-encoding interleukin (IL)-5, together with Calca-encoding calcitonin gene-related peptide (CGRP) and its cognate receptor components. CGRP in concert with IL-33 and neuromedin U (NMU) supported IL-5 but constrained IL-13 expression and ILC2 proliferation. Without CGRP signaling, ILC2 responses and worm expulsion were enhanced. Collectively, these data point to CGRP as a context-dependent negative regulatory factor that shapes innate lymphocyte responses to alarmins and neuropeptides during type 2 innate immune responses.

Details

Language :
English
Database :
OpenAIRE
Journal :
Immunity
Accession number :
edsair.doi.dedup.....f79a323e431b0d9fce7d4718389926ed